Ozanimod Hydrochloride is the hydrochloride salt form of Ozanimod, a selective sphingosine-1-phosphate (S1P) receptor modulator. It’s used for its immunomodulatory effects, mainly in autoimmune diseases. It is grouped under the following drug class(es): Immunosuppressants. Its therapeutic use is listed as multiple sclerosis agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Zeposia, Ozanimod hcl and RPC-1063 HCL. Its PubChem CID is 91618104.
Ozanimod hydrochloride
| CAS No | 1618636-37-5 |
|---|---|
| Molecular Formula | C23H25ClN4O3 |
| Molecular Weight | 440.9 g/mol |
| Synonyms | 5-[3-[(1S)-1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-propan-2-yloxybenzonitrile;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ozanimod Hydrochloride is the hydrochloride salt form of Ozanimod, a selective sphingosine-1-phosphate (S1P) receptor modulator. It's used for its immunomodulatory effects, mainly in autoimmune diseases.
The listed CAS number is 1618636-37-5.
The listed molecular formula is C23H25ClN4O3.
The listed molecular weight is 440.9 g/mol.
5-[3-[(1S)-1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-propan-2-yloxybenzonitrile;hydrochloride.
The source lists Zeposia, Ozanimod hcl and RPC-1063 HCL.